Leaderboards/Ovarian function and disorders

Ovarian function and disorders

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Simon Hanassab
Imperial College London
2
Reproduct Editor
Unknown
3
Baoying Liao
Ministry of Education of the People's Republic of China
4
Chuyu Yun
Peking University
5
Natalia Anna Stańczak
Medical University of Lublin
6
Arghavan Ghafari
Shahid Beheshti University of Medical Sciences
7
Masoome Jabarpour
Shariati Hospital
8
Ruobing Lei
Chinese Academy of Medical Sciences & Peking Union Medical College
9
Jeshica Bulsara
KES College
10
Ruiqiong Zhou
Guangdong Province Women and Children Hospital

Papers

1
The prospect of artificial intelligence to personalize assisted reproductive technology
npj Digital Medicine|2024
80 cit.
2
The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice
Nature Metabolism|2024
80 cit.
3
Publication in Annals of Medicine (2024) [76 citations, W4400370050]
Annals of Medicine|2024
76 cit.
4
Advances in the study of the correlation between insulin resistance and infertility
Frontiers in Endocrinology|2024
64 cit.
5
Publication in Endocrine and Metabolic Science (2025) [37 citations, W4408101604]
Endocrine and Metabolic Science|2025
37 cit.
6
Explainable artificial intelligence to identify follicles that optimize clinical outcomes during assisted conception
Nature Communications|2025
30 cit.
7
Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS
Journal of Cellular and Molecular Medicine|2024
21 cit.
8
Impact of different progesterone timings on live birth rates for blastocyst frozen embryo transfer cycles
Reproductive BioMedicine Online|2024
5 cit.
9
Interleukin-22 improves ovulation in polycystic ovary syndrome via STAT3 signaling
Molecular Human Reproduction|2024
5 cit.
10
Nonlinear correlation between serum vitamin D levels and the incidence of endometrial polyps in infertile women
Human Reproduction|2024
5 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Anju E. Joham
Monash Health
2
Yanli Pang
Peking University
3
Changtao Jiang
Peking University
4
Katrina Tan
Monash Health
5
Niloufar Bagheri
University of Tehran
6
Zatollah Asemi
Kashan University of Medical Sciences
7
Lei Jin
Tongji Hospital
8
Shigang Zhao
Shandong University
9
Guimin Hao
Hebei Medical University
10
Jianjun Zhou
Fudan University

Papers

1
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
The Journal of Clinical Endocrinology & Metabolism|2023
750 cit.
2
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
European Journal of Endocrinology|2023
419 cit.
3
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Fertility and Sterility|2023
332 cit.
4
Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Cell|2024
275 cit.
5
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Nature|2022
211 cit.
6
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Human Reproduction|2023
193 cit.
7
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Science|2023
166 cit.
8
Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development
Frontiers in Endocrinology|2022
150 cit.
9
Systemic and ovarian inflammation in women with polycystic ovary syndrome
Journal of Reproductive Immunology|2022
114 cit.
10
The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice
Nature Metabolism|2024
80 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Stephen Franks
Hammersmith Hospital
2
Andrea Dunaif
Icahn School of Medicine at Mount Sinai
3
Bart C.J.M. Fauser
Semmelweis University
4
Ricardo Azziz
University of Alabama at Birmingham
5
Paul Devroey
Université Libre de Bruxelles
6
Rogerio A. Løbo
Columbia University Irving Medical Center
7
António Pellicer
Valencian Infertility Institute
8
Robert J. Norman
The University of Adelaide
9
Robert F. Casper
Lunenfeld-Tanenbaum Research Institute
10
Zi‐Jiang Chen
Shandong University

Papers

1
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
The Journal of Clinical Endocrinology & Metabolism|2004
2.7k cit.
2
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Endocrine Reviews|1997
2.5k cit.
3
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
The Journal of Clinical Endocrinology & Metabolism|2006
2.1k cit.
4
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Fertility and Sterility|2011
2k cit.
5
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Diabetes|1989
1.9k cit.
6
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women<sup>1</sup>
The Journal of Clinical Endocrinology & Metabolism|1999
1.5k cit.
7
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study<sup>1</sup>
The Journal of Clinical Endocrinology & Metabolism|1998
1.5k cit.
8
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Endocrine Reviews|1997
1.2k cit.
9
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
The Journal of Clinical Endocrinology & Metabolism|2004
1.1k cit.
10
Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
BMJ|1986
994 cit.

Reagents for Ovarian function and disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Beckman Coulter

Access Anti-Müllerian hormone Kit

Cited in 10 papers
#B13127
View Evidence →
Cell Signaling TechnologyEvidence 67

Transferrin Receptor/CD71 (H68.4) Mouse Monoclonal Antibody

Cited in 9 papers
#46222$158,348
View Evidence →
Beckman Coulter

EIA AMH/MIS

Cited in 8 papers
#A11893
View Evidence →

🌟 All-Time

Most validated

Beckman Coulter

AMH/Mullerian-inhibiting substance ELISA kit

Cited in 39 papers
#A79765
View Evidence →
Beckman Coulter

AMH Gen II ELISA kit

Cited in 12 papers
#A73818
View Evidence →
Cell Signaling TechnologyEvidence 67

CD68 (E3O7V) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 700 Conjugate)

Cited in 11 papers
#37129$458
View Evidence →